Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Pediatr Ophthalmol Strabismus ; 56(1): 28-34, 2019 Jan 23.
Artigo em Inglês | MEDLINE | ID: mdl-30371918

RESUMO

PURPOSE: To determine the prevalence of reduced visual acuity and ocular disease in the children of migrant farmworkers in Georgia. METHODS: A retrospective chart review of data acquired by a vision screening was performed on 156 Haitian and Hispanic children of migrant farmworkers attending a summer school in Georgia. Reduced visual acuity at presentation was analyzed and stratified by ethnicity, type of ocular disease, and immediate resolution with refractive correction. RESULTS: The authors found that 20% of migrant farmworker children have a high prevalence of reduced visual acuity in the worse eye. Of those with worse-eye reduced visual acuity, 83% had uncorrected refractive error. The prevalence of uncorrected refractive error from astigmatism and high astigmatism was significantly higher among Hispanics than Haitians. The prevalence of amblyopia suspects among migrant farmworker children was 3%. Of the amblyopia suspects, 80% were anisometropic. CONCLUSIONS: Children of migrant farmworkers in Georgia have a higher rate of reduced visual acuity, largely from uncorrected refractive error, when compared to other Hispanic and African American children in the United States with a prevalence more aligned to children in Asian and Latin American countries than school children in the United States. This illustrates the need for improved access to screening and care in this vulnerable population. [J Pediatr Ophthalmol Strabismus. 2019;56(1):28-34.].


Assuntos
Oftalmopatias/etnologia , Fazendeiros , Migrantes , Transtornos da Visão/etnologia , Seleção Visual/métodos , Acuidade Visual , Adolescente , Criança , Pré-Escolar , Oftalmopatias/fisiopatologia , Feminino , Haiti/etnologia , Humanos , Incidência , Masculino , México/etnologia , Estudos Retrospectivos , Estados Unidos/epidemiologia , Transtornos da Visão/fisiopatologia
2.
Am J Ophthalmol ; 168: 110-121, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27130372

RESUMO

PURPOSE: To describe an economic (Ec) model for estimating the impact of screening and treatment for retinopathy of prematurity (ROP). DESIGN: EcROP is a cost-effectiveness, cost-utility, and cost-benefit analysis. METHODS: We surveyed caregivers of 52 children at schools for the blind or pediatric eye clinics in Atlanta, Georgia and 43 in Mexico City. A decision analytic model with sensitivity analysis determined the incremental cost-effectiveness (primary outcome) and incremental monetary benefit (secondary outcome) of an ideal (100% screening) national ROP program as compared to estimates of current practice. Direct costs included screening and treatment expenditures. Indirect costs estimated lost productivity of caretaker(s) and blind individuals as determined by face-to-face surveys. Utility and effectiveness were measured in quality-adjusted life years and benefit in US dollars. EcROP includes a sensitivity analysis to assesses the incremental cost-effectiveness and societal impact of ROP screening and treatment within a country or economic region. Estimates are based on evidence-based clinical data and region-specific economic data acquired from direct field survey. RESULTS: In both Mexico and the United States, an ideal national ROP screening and treatment program was highly cost-saving. The incremental net benefit of an ideal ROP program over current practice is $5556 per child ($206 574 333 annually) and $3628 per child ($205 906 959 annually) in Mexico and the United States, respectively. CONCLUSION: EcROP demonstrates that ROP screening and treatment is highly beneficial for quality of life, cost saving, and cost-effectiveness in the United States and Mexico. EcROP can be applied to any country or region to provide data for informed allocation of limited health care resources.


Assuntos
Custos de Cuidados de Saúde , Retinopatia da Prematuridade/economia , Criança , Análise Custo-Benefício , Feminino , Humanos , Recém-Nascido , Masculino , México , Modelos Econômicos , Triagem Neonatal/economia , Anos de Vida Ajustados por Qualidade de Vida , Retinopatia da Prematuridade/terapia , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA